MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517054158 A) filed by Gmp Biotechnology Limited; and Trieu, Vuong, Hong Kong, on June 4, for 'compositions and methods for cns diseases.'
Inventor(s) include Trieu, Vuong.
The application for the patent was published on Aug. 22, under issue no. 34/2025.
According to the abstract released by the Intellectual Property India: "This invention describes agents, methods, compositions, kits and uses of medicaments for inhibiting or suppressing expression of TGF-2 for treating or ameliorating the symptoms of a CNS disease in a human subject or animal, including diffuse midline glioma (DMG) and K27M GBM. The agents may be used in combination with cancer drugs. These purposes can be achieved with formulations of agents for inhibiting or suppressing expression of TGF-2. More particularly, this invention discloses compositions, methods and uses for antisense oligonucleotides against TGF-2, in a regimen for CNS disease. This invention further describes novel devices and methods for delivering a pharmaceutical composition by intracranial infusion."
The patent application was internationally filed on Nov. 08, 2023, under International application No.PCT/US2023/079070.
Disclaimer: Curated by HT Syndication.
